Abstract

Henry Schein, Inc. will report its quarterly results on May 5, 2026 Pre-Market, with consensus pointing to modest revenue growth and improving earnings as investors weigh execution on cost discipline, technology-driven contributions, and governance changes.

Market Forecast

Consensus for the current quarter points to total revenue of 3.34 billion US dollars, up 3.57% year over year, and adjusted EPS of 1.22, up 9.67% year over year; EBIT is projected at 233.14 million US dollars, up 6.20% year over year. Forecasts do not explicitly guide to a gross profit margin or net profit margin for the quarter. The company’s main business remains anchored by Global Distribution and Value-Added Services, which accounted for 11.12 billion US dollars in the latest revenue breakdown, with management and market watchers looking for steady volume normalization and product mix support. The segment with the highest perceived growth potential is Global Technology at 675.00 million US dollars, where recurring revenue and software-enabled solutions are viewed as potential accelerants; segment-level year-over-year data is not disclosed in the retrieved dataset.

Last Quarter Review

In the prior quarter, Henry Schein, Inc. delivered revenue of 3.44 billion US dollars, a gross profit margin of 30.93%, GAAP net profit attributable to shareholders of 101.00 million US dollars, a net profit margin of 2.94%, and adjusted EPS of 1.34, up 12.61% year over year. A notable financial highlight was the top- and bottom-line beat versus consensus: revenue exceeded the estimate by approximately 2.68% and adjusted EPS surpassed by about 3.08%. Within the business mix, Global Distribution and Value-Added Services contributed 11.12 billion US dollars, while company-level revenue grew 7.71% year over year, indicating broad-based demand stabilization that supported operational results.

Current Quarter Outlook

Main business: Global Distribution and Value-Added Services

This quarter’s setup for Global Distribution and Value-Added Services is primarily about sustaining stable procedure-driven demand, managing price and mix, and continuing to normalize inventory and service levels across dental and medical channels. The consolidated forecast for the company implies revenue growth of 3.57% year over year and adjusted EPS growth of 9.67% year over year, which suggests an earnings cadence that benefits from underlying cost discipline and improved operating leverage even as top-line growth is modest. The gross profit margin last quarter stood at 30.93%, and while there is no explicit new margin guide for this period, investors will watch whether product mix, vendor incentives, and logistical efficiencies can sustain or improve that level. Execution focus within this segment remains on timely fill rates, availability of core consumables, and disciplined pricing strategies that can offset inflationary cost elements without dampening volume. The revenue surprise achieved last quarter indicates improved forecasting and ordering patterns relative to customer demand, which, if maintained, could buffer near-term variability. A steady sourcing and rebate environment would support gross margin stability, while sustained operating cost control under the company’s strategic programs can translate incremental sales into better operating profit conversion. The quarter is also expected to showcase the benefits of governance and organizational simplification in driving execution. The announced board resizing to 10 members after the May 21, 2026 annual meeting and senior leadership adjustments are seen as complementary to sharpening the focus on core segments. If operations continue to progress in line with the last quarter’s performance momentum and if logistical costs remain contained, the segment can underpin the consolidated outlook and help bridge modest revenue growth to higher earnings per share.

Most promising business: Global Technology

Global Technology at 675.00 million US dollars is widely seen as the stickier, higher-value portion of the portfolio that can provide recurring revenue, attach rates to core distribution, and incremental cross-sell opportunities across practice-management and digital workflows. Although segment-level year-over-year growth was not disclosed in the retrieved dataset, forward commentary from the analyst community has consistently framed technology-enabled offerings as a driver of earnings quality, margin resiliency, and revenue visibility. For this quarter, the key watch items include subscription renewal rates, new-seat adds, and adoption of digital solutions tied to practice efficiency, which together can contribute to a more consistent revenue stream than purely transactional categories. The earnings cadence implied by consensus, with adjusted EPS projected to rise 9.67% year over year while revenue increases 3.57% year over year, is consistent with an expanding contribution from technology and services layers. If software, digital equipment, and integrated services maintain growth, they can help mitigate any short-term variability in procedural volumes and enhance overall margin mix. Additionally, implementation and support revenues associated with larger technology deployments can smooth seasonality and deepen customer relationships, potentially supporting both retention and share-of-wallet. From a strategic standpoint, technology can function as a multiplier for the broader distribution ecosystem, improving practice efficiency and tying customers into multi-year service relationships. Even absent explicit segment growth percentages, investors will focus on signals such as backlog, pipeline builds for software modules, and engagement metrics that indicate whether the technology flywheel is strengthening. Positive updates here would reinforce the narrative that higher-quality recurring revenue can support multi-quarter earnings compounding.

Key stock-price drivers this quarter

Guidance framing and its credibility will likely be central to the stock’s near-term path. The company’s stated range for fiscal 2026 non-GAAP EPS of 5.23 to 5.37 provides an anchor against which investors can assess quarterly progress; delivery in line with or modestly ahead of the current-quarter consensus would underpin confidence that this range is attainable. Investors will pay close attention to whether management’s commentary indicates firming pricing, consistent vendor rebates, and sustainable cost controls that together validate the projected earnings trajectory. Governance and organizational streamlining may influence sentiment as the market evaluates the potential for faster decision-making and stronger accountability. The planned reduction of the board to 10 members after May 21, 2026 is interpreted by many as a move to sharpen strategic focus and accelerate operational execution. If investors perceive that these changes are yielding tangible cost and speed benefits—reflected in stable to improving margins, trimmed overhead, or tighter working capital metrics—that could support multiple stability or expansion. External perceptions from the sell side will also be influential this quarter. Ratings and price-target actions in recent weeks have trended positive, and the market will watch whether the numbers and qualitative commentary reinforce those constructive views. Upside relative to expectations on revenue quality—particularly any mix shift toward technology and services—and evidence of durable margin control could be rewarded. Conversely, a miss on operating leverage or a disappointing margin print versus last quarter’s 30.93% gross margin and 2.94% net margin would test conviction in the near-term trajectory, so clarity on cost, pricing, and mix will be critical in the call narrative.

Analyst Opinions

Across the views dated from January 1, 2026 through April 28, 2026, the ratio of bullish to bearish stances is approximately 6:1 when excluding neutral opinions, indicating a clear majority on the positive side. The bullish camp anchors around the premise that modest revenue growth can still translate into disproportionate earnings gains via cost discipline, mix improvements, and contribution from technology and value-added services. Bank of America Securities, with analyst Allen Lutz, reaffirmed a Buy rating and a 96.00 US dollars price target, highlighting the opportunity for incremental margin progress as the business digests efficiency initiatives and as technology-related offerings contribute a steadier revenue mix. Barclays, led by Glen Santangelo, maintained a Buy with an 86.00 US dollars target, indicating confidence that the company can execute to consensus revenue growth of 3.57% and adjusted EPS growth of 9.67% this quarter while retaining flexibility on cost. J.P. Morgan, represented by John Stansel, also maintained a Buy with a 78.00 US dollars target, emphasizing the supportive earnings setup implied by the latest quarterly beat and steady operational cadence. Additional positive voices reinforce the constructive stance. Baird upgraded the shares to Outperform with a 100.00 US dollars target, citing room for further improvement in dental-related operations and the potential for technology-enabled services to support earnings quality. Citigroup initiated coverage at Buy with a 100.00 US dollars price target, flagging an attractive risk-reward profile if the multi-quarter plan to lift earnings through operating leverage and software-enabled services continues to materialize. Evercore ISI maintained an Outperform rating with a 90.00 US dollars target, reflecting continued belief in a multi-year margin and EPS progression underpinned by recurring and value-added components within the portfolio. While neutral opinions exist—such as BTIG’s Neutral initiation and a Hold view at another firm—the majority perspective emphasizes that the company’s execution track record in the last reported quarter strengthens confidence heading into the print. Bulls point to the prior revenue and EPS beat, last quarter’s 30.93% gross margin showing, and the 2.94% net margin as baselines that could be sustained or improved with stable volumes, disciplined pricing, and mix tailwinds. They also point to the fiscal 2026 non-GAAP EPS range of 5.23 to 5.37 as an achievable framework if the organization continues to show consistent operating control across core distribution and technology lines. From a mechanism standpoint, bullish analysts tend to model incremental gross profit per unit improving as fulfillment costs normalize and as vendor programs stabilize, with SG&A growth lagging revenue growth. The translation of a 3.57% revenue increase into a 9.67% EPS increase is viewed as indicative of positive operating leverage—helped by a more digital and service-oriented mix. If the company can demonstrate that the Global Technology segment maintains healthy momentum—through renewals, attach rates, and new deployments—then some analysts see room for annual EPS to land in the upper half of the stated fiscal 2026 range. Altogether, the prevailing view among covering analysts is that the quarter can meet or slightly exceed current expectations on revenue while showing continued strength in earnings conversion. The focus will be on margin commentary and any color on technology and services traction. Stronger-than-anticipated progress on those fronts would validate the majority’s constructive price targets in the mid-to-high 80s and near 100.00 US dollars, consolidating the bullish thesis heading into subsequent quarters.